Christian Pagnoux Selected Research

Systemic Vasculitis

12/2021	An Initiative to Improve Timely Glucocorticoid Tapering in Vasculitis.
10/2020	Management of cutaneous vasculitis.
9/2017	Investigational drugs in systemic vasculitis.
1/2017	Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
2/2014	ANCA-associated diseases and lung carcinomas: a five-case series.
1/2008	Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
5/2007	[Treatment of ANCA-associated vascularitides].
2/2007	Indications for biotherapy in systemic vasculitides.
4/2003	When should immunosuppressants be prescribed to treat systemic vasculitides?
4/2003	Indications of plasma exchanges for systemic vasculitides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian Pagnoux Research Topics

Disease

75	Vasculitis (Vasculitides) 01/2022 - 04/2003
37	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2022 - 04/2003
31	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2022 - 05/2007
28	Churg-Strauss Syndrome (Allergic Angiitis) 05/2022 - 04/2003
28	Microscopic Polyangiitis 01/2022 - 04/2003
14	Polyarteritis Nodosa (Periarteritis Nodosa) 04/2020 - 04/2003
13	Asthma (Bronchial Asthma) 06/2020 - 10/2004
11	Infections 07/2021 - 04/2003
10	Inflammation (Inflammations) 01/2022 - 11/2005
10	Systemic Vasculitis 12/2021 - 04/2003
8	Giant Cell Arteritis (Horton Disease) 01/2022 - 08/2013
8	Glomerulonephritis 06/2020 - 04/2003
7	Takayasu Arteritis (Arteritis, Takayasu's) 01/2022 - 01/2014
7	Hemorrhage 06/2020 - 04/2007
6	Eosinophilia 01/2019 - 10/2004
5	Neoplasms (Cancer) 03/2021 - 05/2007
4	Arthralgia (Joint Pain) 01/2022 - 12/2010
4	Pain (Aches) 01/2022 - 07/2010
4	Mononeuropathies (Mononeuritis Multiplex) 01/2020 - 05/2008
4	Necrosis 03/2019 - 11/2005
4	Primary angiitis of the central nervous system 10/2018 - 12/2013
4	Cryoglobulinemia 05/2008 - 04/2003
3	Purpura 01/2022 - 04/2020
3	Hematuria 10/2021 - 10/2011
3	Arthritis (Polyarthritis) 01/2019 - 07/2008
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2013 - 11/2005
2	Rare Diseases (Rare Disease) 05/2022 - 01/2016
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 06/2008
2	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 10/2020 - 10/2011
2	Skin Manifestations 06/2020 - 11/2008
2	Polyneuropathies (Polyneuropathy) 06/2020 - 05/2008
2	Proteinuria 01/2020 - 11/2010
2	Cardiomyopathies (Cardiomyopathy) 01/2020 - 01/2007
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 11/2015
2	Central Nervous System Vasculitis 01/2018 - 11/2012
2	Pathologic Constriction (Stenosis) 08/2015 - 03/2012
2	Carcinoma (Carcinomatosis) 02/2014 - 03/2012
2	Fibrosis (Cirrhosis) 04/2013 - 05/2007
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2012 - 04/2007
2	Autoimmune Diseases (Autoimmune Disease) 01/2012 - 06/2011
2	Fever (Fevers) 11/2010 - 11/2005
2	Systemic Scleroderma (Systemic Sclerosis) 09/2010 - 06/2008
1	Fatigue 01/2022

Drug/Important Bio-Agent (IBA)

52	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2022 - 10/2004
25	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 04/2003
24	GlucocorticoidsIBA 01/2022 - 05/2002
22	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2015 - 10/2004
20	Rituximab (Mabthera)FDA Link 11/2021 - 05/2006
17	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2021 - 09/2005
16	Azathioprine (Imuran)FDA LinkGeneric 04/2020 - 09/2003
13	AntibodiesIBA 06/2020 - 10/2004
12	AutoantibodiesIBA 01/2021 - 01/2005
10	Peroxidase (Myeloperoxidase)IBA 01/2022 - 10/2004
10	Biological ProductsIBA 10/2021 - 10/2004
7	Prednisone (Sone)FDA LinkGeneric 03/2022 - 10/2004
6	CreatinineIBA 10/2021 - 05/2007
6	Antiviral Agents (Antivirals)IBA 04/2017 - 04/2003
5	AntigensIBA 06/2020 - 09/2005
4	C-Reactive ProteinIBA 01/2022 - 06/2007
4	Peptide Hydrolases (Proteases)FDA Link 03/2021 - 01/2005
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2015
4	Myeloblastin (Proteinase 3)IBA 03/2015 - 05/2007
4	Intravenous Immunoglobulins (IVIG)FDA Link 11/2008 - 02/2007
3	avacopanIBA 01/2021 - 10/2020
3	Antigen-Antibody Complex (Immune Complex)IBA 02/2020 - 09/2005
3	CytokinesIBA 03/2019 - 02/2007
3	ametantrone (HAQ)IBA 05/2016 - 07/2008
3	Methotrexate (Mexate)FDA LinkGeneric 03/2016 - 12/2008
2	Leflunomide (Arava)FDA LinkGeneric 03/2021 - 07/2014
2	Anaphylatoxin C5a ReceptorIBA 11/2020 - 10/2020
2	Pharmaceutical PreparationsIBA 04/2020 - 04/2005
2	Colchicine FDA LinkGeneric 04/2020 - 11/2008
2	Immunoglobulin A (IgA)IBA 04/2020 - 03/2017
2	mepolizumabIBA 03/2020 - 01/2019
2	GadoliniumIBA 10/2018 - 05/2014
2	SteroidsIBA 11/2017 - 04/2003
2	Immunoglobulin G (IgG)IBA 03/2017 - 09/2009
2	Abatacept (Orencia)FDA Link 01/2017 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 05/2015 - 02/2007
2	Interleukin-6 (Interleukin 6)IBA 05/2015 - 11/2010
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2014 - 12/2010
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 04/2013 - 02/2011
2	VaccinesIBA 01/2012 - 06/2011
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2008 - 06/2007
2	oxidized low density lipoproteinIBA 09/2008 - 06/2007
2	Monoclonal AntibodiesIBA 05/2007 - 02/2007
2	Interferon-alpha (Interferon Alfa)IBA 05/2007 - 02/2007
2	anti-IgE antibodiesIBA 05/2007 - 02/2007
1	SolutionsIBA 03/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	N 30IBA 01/2022

Therapy/Procedure

37	Therapeutics 01/2022 - 09/2003
7	Plasma Exchange 01/2020 - 04/2003
6	Remission Induction 07/2021 - 09/2017
4	Biological Therapy 02/2008 - 02/2007
2	Aftercare (After-Treatment) 11/2010 - 09/2005
2	Duration of Therapy 03/2008 - 04/2003
1	Immunotherapy 01/2022